Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Hye Ryun Kim"'
Autor:
You Jin Chun, Kwang Joon Kim, Ji Yeon Lee, Ji Won Choi, Tae Hee Kim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong, Chang Oh Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 2, Pp 254-263 (2023)
Background/Aims The prognostic value of a comprehensive geriatric assessment (CGA) for the management of older small cell lung cancer (SCLC) patients remains to be established. Methods A retrospective cohort enrolled 21 SCLC patients over 65 years fr
Externí odkaz:
https://doaj.org/article/cd524618972c48deac276619385581e8
Autor:
Seo Hee Choi, Andrew Jihoon Yang, Sun Och Yoon, Hye Ryun Kim, Min Hee Hong, Se-Heon Kim, Eun Chang Choi, Ki Chang Keum, Chang Geol Lee
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Purpose Although postoperative radiotherapy (PORT) is demonstrably effective in local control of head and neck adenoid cystic carcinoma (HNACC), its application is controversial and the subset of patients who would benefit most from PORT is
Externí odkaz:
https://doaj.org/article/9d9368cf85a244fe91179b3b180402e8
Autor:
Tae Hyung Kim, In-Ho Cha, Eun Chang Choi, Hye Ryun Kim, Hyung Jun Kim, Se-Heon Kim, Ki Chang Keum, Chang Geol Lee
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background/PurposeSurgery followed by postoperative radiotherapy (RT) has been considered the standard treatment for oral cavity squamous cell carcinoma (OCSCC) of advanced stages or with adverse prognostic factors. In this study, we compared the out
Externí odkaz:
https://doaj.org/article/54c13f8ba0c24d52b97b8f9ba99d8703
Autor:
Gun Min Kim, Seung Jun Kim, Su Kyung Song, Hye Ryun Kim, Beo Deul Kang, Sung Hoon Noh, Hyun Cheol Chung, Kyung Ran Kim, Sun Young Rha
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background The aim of this study was to investigate the prevalence and prognostic significance of psychological distress in gastric cancer patients. Methods The study population included 229 gastric cancer patients visiting Yonsei Cancer Cen
Externí odkaz:
https://doaj.org/article/f662858fefdd43d28187b4bf19cff375
Autor:
Hyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, Jang Ho Cho, Jong-Kwon Choi, Keon Uk Park, Eun Joo Kang, Keun-Wook Lee, Sun Min Lim, Jin-Soo Kim, Hyun Woo Lee, Min Kyoung Kim, In Gyu Hwang, Sangwoo Kim, Byung-Ho Nam, Hye Ryun Kim
Publikováno v:
Cancers, Vol 12, Iss 7, p 1777 (2020)
Immune system dysfunction is associated with head and neck squamous cell carcinoma (HNSCC) development and progression and immune checkpoint inhibitors have demonstrated substantial survival benefits in platinum-refractory HNSCC; therefore, we examin
Externí odkaz:
https://doaj.org/article/46d0b85d07d64d74a0df609ce27a603f
Autor:
Sang Jun Ha, Daehee Hwang, Eun Chang Choi, Min Hee Hong, Se-Heon Kim, Hye Ryun Kim, Sun Min Lim, Sun Och Yoon, Da Hee Kim, Yoon Woo Koh, Sehyun Chae
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:2741-2750
We aimed to investigate the prognostic value of multiple immune cell markers including programmed death-ligand 1 (PD-L1) and poliovirus receptor (PVR) in head and neck squamous cell carcinoma (HNSCC) using archival tumor tissues METHODS: Patients dia
Autor:
Hye Ryun Kim, Hyun Chang, Keun-Wook Lee, Myung-Ju Ahn, Seong Hoon Shin, Ho Jung An, Sung-Bae Kim, Sang Hoon Chun, Yun-Gyoo Lee, Ji Hyun Park, Kyoung Eun Lee, In Gyu Hwang, Keon Uk Park, Bhumsuk Keam
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study was conducted to determine the effectiveness of immune checkpoint inhibitors (ICIs) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum-containing chemotherapy. We also identified clinical bi
Autor:
Bong Seog Kim, Heung Tae Kim, Sang We Kim, Joo Hang Kim, Joung Soon Jang, Dong Wan Kim, Ki Hyeong Lee, Jin-Soo Kim, Ho Jung An, Jin Hyoung Kang, Hye Ryun Kim, Jin-Hyuk Choi
Publikováno v:
British Journal of Cancer
Background This study compared the efficacy/safety of the camptothecin analogues belotecan and topotecan for sensitive-relapsed small-cell lung cancer (SCLC). Methods One-hundred-and-sixty-four patients were randomised (1:1) to receive five consecuti
Autor:
Hye Ryun Kim, Min Hee Hong, Sang Jun Ha, Insuk Lee, Byoung Chul Cho, Young Joon Kim, Jae Won Cho
Publikováno v:
Experimental & Molecular Medicine
Experimental and Molecular Medicine, Vol 52, Iss 9, Pp 1550-1563 (2020)
Experimental and Molecular Medicine, Vol 52, Iss 9, Pp 1550-1563 (2020)
Although approved programmed cell death protein (PD)-1 inhibitors show durable responses, clinical benefits to these agents are only seen in one-third of patients in most cancer types. Therefore, strategies for improving the response to PD-1 inhibito
Autor:
Sang We Kim, Young Joo Min, Gyeong Won Lee, Dong Wan Kim, Jin Seok Ahn, Ki Hyeong Lee, Byoung Chul Cho, Jong Seok Lee, Myung-Ju Ahn, Sung Sook Lee, Jin Soo Kim, Dae Ho Lee, Eun Kyung Cho, Jong Mu Sun, Sohee Kim, Joo Hang Kim, Min Hee Hong, Hye Ryun Kim, Ji Youn Han, Yun Gyoo Lee, Heung Tae Kim
Publikováno v:
The Lancet Oncology. 20:1681-1690
Summary Background Patients with EGFR-mutated non-small-cell lung cancer (NSCLC) given EGFR tyrosine kinase inhibitors (TKIs) inevitably become resistant to first-generation or second-generation drugs. We assessed the safety, tolerability, pharmacoki